mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.8 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |